00:00 Speaker A
Let’s get to some individual names too. We’ve talked about the sort of vanity trade before, the beauty trade before, and I know that’s one that you’re still sticking with at least, um, with some some stocks here and there. Um, Victoria’s Secret is one of those. Visco is the ticker on that one. Um, and you know, we know retail has been kind of uneven, right? So, um, you know, what is it about that that chart and that stock that you like?
00:24 Speaker B
Well, it’s in a bullish trend. It’s held up very well. It isn’t at the highs, but obviously, you know, I always like to preface things by saying if we have a major sell-off, everything’s going to sell off. But if things stay relatively calm or the sell-off is more controlled and the Iranian situation goes away, which is also putting pressure. We like Victoria’s Secret the is the support right now I would say is at about 55 to 58. If we can get through most recent high 62, 63,
00:50 Speaker B
there’s no reason why that can’t go to new all-time highs. I think that Victoria’s Secret is benefiting, benefiting from the diet drugs and people now feeling better about themselves. Um, so that’s a happy news. And and that’s why we’re long this particular stock. If you look at that chart right now, you can see how it could be setting up either for a big top if it doesn’t get through those highs or at the very least, uh if it holds the support, maybe new highs from here.
01:08 Speaker A
Well, speaking of GLP1s, you like Novo also. Um that chart looks very different to the Victoria’s Secret chart, doesn’t it?
01:15 Speaker B
Yes it does.
01:16 Speaker A
Um,
01:17 Speaker B
I’m liking it enough.
01:19 Speaker A
Yeah, talk to me, talk to me about that one because Lily has really seemed to gain some ground and even the introduction of the pill that Novo has come out with hasn’t really seemed to to help the stock that much.
01:27 Speaker B
Yes, and it’s been, you know, a little bit in the headlines with what happened with Hims and then of course other companies like uh Viking therapeutics now talking about a pill. Um so there’s competition. However, it’s Novo Nordisk. It’s a big drug company. I think they have the means to to to continue to stay in the game. You know, you can see that it’s at 4773, again pressure, but I think if it can get back over 50 to 52, um that bottom looks pretty solid right now.
01:51 Speaker B
It just might be in a long period of consolidation. um but overall, I we’re still very long-term bullish.
01:56 Speaker A
And then um switching gears a little bit, um another one that you’re looking at, um BMNR, uh which is Bitmine. Um, we haven’t talked much about crypto today, but that’s obviously a stock play on crypto, on Ethereum specifically. Um, but that’s been that sector’s been rough as of late.
02:09 Speaker B
Yeah. Well, I have I mean, I have to say, to be completely honest, I have a sense that Ethereum, particularly, I’m more interested in that than Bitcoin right now. Although Bitcoin you have to watch obviously because it influences everything. But my sense is that Ethereum is what silver was a few years ago, undervalued, something that’s going to come into vogue more and more as we get closer to even possibly the clarity act being passed, but stable coins, we need
02:32 Speaker B
Ethereum. And so it’s I feel like it’s being held down. I couldn’t I mean, I know that there’s been a lot of buying now at these levels. I’m finding that encouraging. You know, I believe in Tom Lee. Uh, I do. I think he’s incredibly brilliant. So if we can hold up here around this 1900 level, we’re in this consolidation, a lot of the volatility that we saw has kind of calmed down. So if we can get back over 2,000 and then over 2100, I think game on. So, yeah, we’re
02:54 Speaker B
watching, we have a position in BMNR. Uh, we have a stop, obviously always do, but we’re looking to add to that position as maybe one of our bigger positions, um, if if if Ethereum cooperates.